Mark J Foley Transaction History

Date Transaction Value Shares Traded Form
Feb 04 2025
SELL
Disposition due to a tender of shares in a change of control transaction
$404,832 $3.65 p/Share
110,913
Nov 29 2021
BUY
Open market or private purchase
$516,000 $12.9 p/Share
40,000
Jul 23 2020
BUY
Grant, award, or other acquisition
-
50,913

Also insider at

GKOS
GLAUKOS Corp Healthcare
MJF

Mark J Foley

President & CEO
Nashville, TN

Track Institutional and Insider Activities on RVNC

Follow Revance Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVNC shares.

Notify only if
Any

Insider Trading

Get notified when an Revance Therapeutics, Inc. insider buys or sells RVNC shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Revance Therapeutics, Inc.

Track Activities on RVNC